Translational Health Science and Technology Institute (THSTI) hosted the first India partner meeting for the DBT-EU Horizon INDIGO project on 3rd May 2024 at its campus in a hybrid mode. The novel vaccine, Tetralite, is poised for Phase I clinical trials in Indian population. This vaccine has completed the Phase I clinical trial in European Union.